Search Results - "Ranuncolo, Stella Maris"

Refine Results
  1. 1
  2. 2
  3. 3

    Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR by Carroll, Martin, Melnick, Ari, Ranuncolo, Stella Maris, Polo, Jose M, Dierov, Jamil, Singer, Michael, Kuo, Tracy, Greally, John, Green, Roland

    Published in Nature Immunology (01-07-2007)
    “…Antibody specificity and diversity is generated in B cells during germinal center maturation through clonal expansion while they undergo class-switch…”
    Get full text
    Journal Article
  4. 4

    Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin Lymphoma by Gamboa-Cedeño, Angélica María, Díaz, Mariángeles, Cristaldo, Nancy, Otero, Victoria, Schutz, Natalia, Fantl, Dorotea, Cugliari, Silvana, Zerga, Marta, Rojas-Bilbao, Erica, Jauk, Federico, García Rivello, Hernán, Nuñez, Myriam, Ranuncolo, Stella Maris

    Published in Life sciences (1973) (01-03-2021)
    “…The challenge in classical Hodgkin Lymphoma (cHL) management is the 30–40% of refractory/relapsed cases. The aim of this work was to determine whether NIK and…”
    Get full text
    Journal Article
  5. 5

    Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells by Melnick, Ari, Polo, Jose M, Dell'Oso, Tania, Ranuncolo, Stella Maris, Cerchietti, Leandro, Beck, David, Da Silva, Gustavo F, Prive, Gilbert G, Licht, Jonathan D

    Published in Nature medicine (01-12-2004)
    “…The BTB/POZ transcriptional repressor and candidate oncogene BCL6 is frequently misregulated in B-cell lymphomas. The interface through which the BCL6 BTB…”
    Get full text
    Journal Article
  6. 6

    BCL6-mediated Attenuation of DNA Damage Sensing Triggers Growth Arrest and Senescence through a p53-dependent Pathway in a Cell Context-dependent Manner by Ranuncolo, Stella Maris, Wang, Ling, Polo, Jose M., Dell’Oso, Tania, Dierov, Jamil, Gaymes, Terry J., Rassool, Feyruz, Carroll, Martin, Melnick, Ari

    Published in The Journal of biological chemistry (15-08-2008)
    “…The BCL6 oncogenic transcriptional repressor is required for development of germinal center centroblasts, which undergo simultaneous genetic recombination and…”
    Get full text
    Journal Article
  7. 7

    CD44 expression in human gliomas by Ranuncolo, Stella Maris, Ladeda, Virginia, Specterman, Sergio, Varela, Mirta, Lastiri, José, Morandi, Ana, Matos, Elena, De Kier Joffe, Elisa Bal, Puricelli, Lydia, Pallotta, María Guadalupe

    Published in Journal of surgical oncology (01-01-2002)
    “…Background and Objectives Glioma invasiveness involves the attachment of tumor cells to the brain extracellular matrix, rich in hyaluronic acid (HA). CD44, the…”
    Get full text
    Journal Article
  8. 8

    Abstract 766: Refractory and relapsed predictive biomarkers in Hodgkin lymphoma and potential directed-therapy targets by Gamboa-Cedeño, Angélica M., Otero, Victoria, Schutz, Natalia, Fantl, Dorotea, Rivello, Hernán, Jauk-Vitali, Federico, Nuñez, Myriam, Ranuncolo, Stella Maris

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Abstract Despite 90% stage I Hodgkin Lymphoma (HL) patients can respond to current therapy, this drops to 60% when diagnosed in late stages. Nevertheless and…”
    Get full text
    Journal Article
  9. 9

    Abstract 4032: The alternative NF-kB pathway activity in refractory and relapsed Hodgkin lymphoma by Gamboa-Cedeño, Angélica María, castillo, Mariángeles, Otero, Victoria, Schutz, Natalia, Fantl, Dorotea, Vitali, Federico Jauk, Rivello, Hernán García, Nuñez, Myriam, Ranuncolo, Stella Maris

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Abstract The refractory and relapsed disease is currently the challenge in Hodgkin Lymphoma (HL) treatment. There is no specific therapy but rescue…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Abstract 3550: Expression of Oct-2, OCA-B, BCL6, PU.1 and IRF8 predicts prognosis in Diffuse Large B Cell Lymphoma patients by Rojas Bilbao, Erica A., Bal de Kier Joffe, Elisa D., Zerga, Marta E., Puricelli, Lydia I., Ranuncolo, Stella Maris N.

    Published in Cancer research (Chicago, Ill.) (01-08-2015)
    “…Abstract Diffuse Large B Cell Lymphoma (DLBCL) is the most common B cell Non Hodgkin lymphoma in adults.  While 50% of patients are cured with standard…”
    Get full text
    Journal Article
  12. 12

    Abstract 1577: Levels of Fibroblast Growth Factor 21 (FGF21) in serum as diagnostic biomarker in patients with breast cancer by Knott, Maria Elena, Ranuncolo, Stella Maris, Nuñez, Myriam, Armanasco, Eduardo, Puricelli, Lydia Ines, De Lorenzo, Mariana Silvia

    Published in Cancer research (Chicago, Ill.) (01-08-2015)
    “…Abstract Epidemiological studies have suggested a close link between obesity and breast cancer. There is an immediate need to investigate the potential…”
    Get full text
    Journal Article
  13. 13

    Abstract 431: Circulating fibroblast growth factor 21 (FGF21) as diagnostic and prognostic biomarker in renal cancer by Knott, Maria Elena, Minatta, Jose Nicolas, Roulet, Lucia, Gueglio, Guillermo, Pasik, Leonardo, Ranuncolo, Stella Maris, Nuñez, Myriam, Puricelli, Lydia Ines, De Lorenzo, Mariana Silvia

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Abstract Clear-cell renal cell carcinoma (ccRCC), the most frequent renal parenchyma malignant neoplasm, is considered a cell metabolic disease. The finding of…”
    Get full text
    Journal Article
  14. 14

    Plasma MMP‐9 (92 kDa‐MMP) activity is useful in the follow‐up and in the assessment of prognosis in breast cancer patients by Ranuncolo, Stella Maris, Armanasco, Eduardo, Cresta, Carlos, Bal de Kier Joffe, Elisa, Puricelli, Lydia

    Published in International journal of cancer (20-09-2003)
    “…Previously we determined that plasma MMP‐9 activity was significantly elevated in breast cancer patients compared to benign mammary pathologies and healthy…”
    Get full text
    Journal Article
  15. 15

    EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas by Varela, Mirta, Ranuncolo, Stella Maris, Morand, Ana, Lastiri, José, Joffé, Elisa Bal De Kier, Puricelli, Lydia Inés, Pallotta, María Guadalupe

    Published in Journal of surgical oncology (01-04-2004)
    “…Background and Objectives Therapy of malignant glioma tumors is based on histology and clinical factors. However, comparable lesions may correspond with…”
    Get full text
    Journal Article
  16. 16

    BCL6-mediated Attenuation of DNA Damage Sensing Triggers Growth Arrest and Senescence through a p53-dependent Pathway in a Cell Context-dependent MannerS by Ranuncolo, Stella Maris, Wang, Ling, Polo, Jose M., Dell'Oso, Tania, Dierov, Jamil, Gaymes, Terry J., Rassool, Feyruz, Carroll, Martin, Melnick, Ari

    Published in The Journal of biological chemistry (15-08-2008)
    “…The BCL6 oncogenic transcriptional repressor is required for development of germinal center centroblasts, which undergo simultaneous genetic recombination and…”
    Get full text
    Journal Article
  17. 17

    The BCL6 Oncoprotein Forms Distinct Transcriptional Repression Complexes on Cohorts of Target Genes Involved in Specific Cellular Functions by Polo, Jose M., Ranuncolo, Stella Maris, Parek, Samir, Arcaya, Jose, Melnick, Ari M.

    Published in Blood (16-11-2005)
    “…The BCL6 (B-Cell-Lymphoma-6) oncoprotein is required for formation of germinal centers by normal B-cells and is frequently constitutively activated in B-cell…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20